Keynote Speakers show quality of World of Health IT Conference & Exhibition

Following on from the success of last year's inaugural World of Health IT Conference & Exhibition (WHIT) in Geneva, the organisers have built on that event's popularity and effectiveness to put together this year's conference at the Austria Center in Vienna, Austria, from 22–25 October 2007.

WHIT, the forum for all professions connected with healthcare IT in the EMEA region, has once again attracted speakers of the highest calibre. For example, the opening keynote address will come from Dr. Muhadditha Al Hashimi, the chief executive officer of Dubai Healthcare City (DHCC).

Dr. Al Hashimi has extensive experience in the healthcare sector, gained from the United States and the United Arab Emirates. She is certain to provide valuable insights into the challenges facing healthcare IT implementation throughout the world.

Holding a doctorate in Public Health from the University of Texas, Houston, Dr. Al Hashimi's role at DHCC sees her responsible for the operational management and quality, development of education, new businesses and customer relationships.

She also oversees the resource allocation to drive consistent excellence throughout DHCC, while working closely with Dubai Healthcare City's partners at Harvard Medical International.

Following on from Dr. Al Hashimi's address will be keynote speeches across the duration of the conference from other heavyweights in healthcare, such as Dr. Hussein A. Gezairy, the WHO Regional Director for the Eastern Mediterranean, Robert M. Kolodner, MD, thenational coordinator for Health IT, Dept of Health and Human Services, USA, Richard Alvarez, president and CEO, Canada Health Infoway and Richard Granger, currently director-general of IT, at the National Health Service, UK.

Meanwhile, outlining the European Commission's latest strategies will be Ilias Iakovidis, the deputy head of unit, ICT for health.

The full programme and further details are available at www.worldofhealthit.org

Related news articles:

About The World of Health IT Conference & Exhibition
The World of Health IT Conference & Exhibition has been developed for leaders and experts in health IT from Europe, the Middle East and Africa (EMEA). It has been designed for and by the healthcare IT community in the EMEA region: technology users, buyers, vendors, providers or healthcare regulators. Addressing the perspectives of clinicians, directors and other healthcare professionals, The World of Health IT Conference & Exhibition offers educational sessions, vendor exhibitions, best practice exchange networking sessions and other professional development opportunities.

The World of Health IT Conference & Exhibition Organising Committee is jointly organised by the EC (European Commission), HIMSS (Healthcare Information and Management Systems Society), EUROREC (European Institute for Health Records), COCIR (European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry), EHTEL (European Health Telematics Association), HINE (Health Information Network Europe), CPME (Standing Committee of European Doctors), EHMA (European Health Management Association), and HOPE (European Hospital and Healthcare Federation).

Most Popular Now

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...

New Recommendations to Increase Transpar…

Patients will be better able to benefit from innovations in medical artificial intelligence (AI) if a new set of internationally-agreed recommendations are followed. A new set of recommendations published in The...

Digital Health Unveils Draft Programme f…

18 - 19 March 2025, Birmingham, UK. Digital Health has unveiled the draft programme for its Rewired 2025 event which will take place at the NEC in Birmingham in March next...

AI System Helps Doctors Identify Patient…

A new study from Vanderbilt University Medical Center shows that clinical alerts driven by artificial intelligence (AI) can help doctors identify patients at risk for suicide, potentially improving prevention efforts...

Smartphone App can Help Reduce Opioid Us…

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a...

AI's New Move: Transforming Skin Ca…

Pioneering research has unveiled a powerful new tool in the fight against skin cancer, combining cutting-edge artificial intelligence (AI) with deep learning to enhance the precision of skin lesion classification...

Leveraging AI to Assist Clinicians with …

Physical examinations are important diagnostic tools that can reveal critical insights into a patient's health, but complex conditions may be overlooked if a clinician lacks specialized training in that area...

AI can Improve Ovarian Cancer Diagnoses

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in ultrasound images. The study is...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...